跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 17,557 条关于
“refractory MTLE”
全部
17,557
临床试验
15,054
药物
85
机构
9
资讯
2,409
去年
uniQure Doses First Patient in Phase I/IIa Trial of AMT-260 for Refractory Mesial Temporal Lobe Epilepsy
去年
uniQure Doses First Patient in Phase I/IIa Trial of AMT-260 for Refractory Mesial Temporal Lobe Epilepsy
去年
uniQure's Gene Therapy AMT-260 Achieves 92% Seizure Reduction in First Drug-Resistant Epilepsy Patient
11个月前
Neurona Therapeutics Receives EMA PRIME Designation for NRTX-1001 Cell Therapy in Drug-Resistant Focal Epilepsy
去年
Neurona Therapeutics to Present at Upcoming Investor Conferences
4年前
First Patient Dosed in Groundbreaking Stem Cell Therapy Trial for Drug-Resistant Epilepsy Shows Dramatic Seizure Reduction
2年前
Odronextamab Shows Durable Responses in Relapsed/Refractory DLBCL
去年
Belantamab Mafodotin Triplet Demonstrates Improved Overall Survival in Relapsed/Refractory Multiple Myeloma
去年
Targeted Therapies Show Similar Safety Profiles in Relapsed/Refractory CLL
去年
FS118, a LAG-3/PD-L1 Bispecific Antibody, Shows Modest Efficacy in Relapsed/Refractory DLBCL
第 1 页,共 241 页
上一页
下一页